Evaluation of Adverse Drug Reaction in Pediatric Tuberculosis Patients at The Tegal District Public Health Center
Article Sidebar
Main Article Content
Page: 2721-2729
Abstract
Tuberculosis (TB) is a disease caused by bacteria, namely Mycobacterium tuberculosis (MTB) and needanti-TB drugs (ATD) treatment. The success of ATD therapy is influenced by various factors, including ADRs and their management, which play a role in treatment and retention in care. The frequency and severity of ADRs caused by ATD are always a concern, especially in children. The study aims to determine the prevalence of ADRs, determine the management and outcome of ADR treatment in pediatric TB patients at the Tegal Regency Community Health Center. This study used a cross-sectional design in pediatric TB patients aged 0-18 years. This study showed The most frequent ADRs were gastrointestinal disturbances (16.7%), joint pain (8.3%), peripheral neuropathy (6.7%), and flu-like syndrome (6.7%). The ADR event category is likely to have a percentage of 91% of the overall number of events, followed by the possibility with a percentage of 9% of events. Management strategies, including vitamin B complex supplementation, antacids, multivitamins, probiotics, antipyretics, and topical agents, effectively reduced or eliminated ADRs. The most common ADRs werw gastrointestinal disorders, joint pain and flu syndrome. Management of ADRs related to anti-tuberculosis drugs (ATD) has been successful in reducing or eliminating ADRs. Special attention from healthcare workers should be given to patients at spesific risk groups for ADR management to improve therapy success.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Diantara LB, Hasyim H, Septeria IP, Sari DT, Wahyuni GT, Anliyanita R. Tuberkulosis masalah kesehatan dunia: tinjauan literatur. Jurnal’Aisyiyah Med 2022;7:78–88. DOI: https://doi.org/10.36729/jam.v7i2.855
Pralambang SD, Setiawan S. Faktor risiko kejadian tuberkulosis di Indonesia. J Biostat Kependudukan, Dan Inform Kesehat 2021;2:5. DOI: https://doi.org/10.51181/bikfokes.v2i1.4660
Falah M, Azzahra F, Ridwan SM, Putriani H, Hidayat TC, Qoyyimah ID, et al. Penyuluhan Kesehatan Tuberculosis (TBC) di Stadion Wiradadaha. HAZIQMAS J Pengabdi Masy 2025;1:6–10.
Alwi NP, Fitri A, Ambarita R. Hubungan motivasi dengan kepatuhan minum Obat Anti Tuberkulosis (OAT) pada pasien Tuberkulosis. J Keperawatan Abdurrab 2021;5:63–6. DOI: https://doi.org/10.36341/jka.v5i1.1891
Abdusalomova M, Denisiuk O, Davtyan H, Gadoev J, Abdusamatova B, Parpieva N, et al. Adverse drug reactions among children with tuberculosis in Tashkent, Uzbekistan, 2019. Int J Environ Res Public Health 2021;18. https://doi.org/10.3390/ijerph18147574. DOI: https://doi.org/10.3390/ijerph18147574
Dirjen P2P. Laporan Program Penanggulangan Tuberkulosis Tahun 2021. Kemenkes RI 2022:1–147.
Anggraini I, Basaria Hutabarat SKM. Tuberkulosis Paru: Faktor Penyebab & Penanggulanganya. Media Nusa Creative (MNC Publishing); 2024.
Saimi SKM, Ariyanti AD. Memahami Tuberkulosis Anak: Temukan Solusi dan Obati Sampai Sembuh. Penerbit Adab; n.d.
Deswita MK, An NSK, Mansur NAR, Kep M, Farlina M, Kep M. Kenali TBC pada Anak dan Tatalaksananya. Penerbit Adab; 2022.
Ashar YK, SKM MKM, Putra Apriadi Siregar SKM, Adilah R, Sembiring SP. Penanggulangan TB Paru Anak Melalui Pemberdayaan Kader Cilik Toss TB. Penerbit Adab; n.d.
Kemenkes RI. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis 2019.
Kemenkes RI. Petunjuk Teknis Tata Laksana Tuberkulosis Anak dan Remaja Indonesia 2023.
Kemenkes RI. Survei Kesehatan Indonesia 2023 (SKI). Kemenkes RI 2023:235.
Efriani L, Jatiningsih S, Perwitasari DA. Pengaruh Karakteristik Pasien terhadap Adverse Drug Reactions di RSUD Dr. M. Yunus Bengkulu. J Permata Indones 2019. DOI: https://doi.org/10.59737/jpi.v10i2.77
Andayani TM, Rahmawati F, Rokhman MR, Mayasari G, Nurcahya BM, Arini YD, et al. Drug related problems: identifikasi faktor risiko dan pencegahannya. UGM PRESS; 2020.
Jannah M, Sari Y, Almasdy D. Study Of the Adverse Drug Reaction (ADR) On Geriatric Patients in Internal Medicine Inpatient at A Private Hospital in Bukittinggi City, West Sumatera. J Farm 2024;6:178–85. DOI: https://doi.org/10.35451/jfm.v6i2.2142
Wahyuni CU, Budiono, Rahariyani LD, Sulistyowati M, Rachmawati T, Djuwari, et al. Obstacles for optimal tuberculosis case detection in primary health centers (PHC) in Sidoarjo district, East Java, Indonesia. BMC Health Serv Res 2007;7:1–9. https://doi.org/10.1186/1472-6963-7-135. DOI: https://doi.org/10.1186/1472-6963-7-135
WHO. WHO consolidated guidelines on tuberculosis. Module 5, Management of tuberculosis in children and adolescents 2022:101.
Ho DKK. Tuberculosis in children. Clin Tuberc A Pract Handb 2015:81–97. https://doi.org/10.1201/b20755-9. DOI: https://doi.org/10.1201/b20755-9
Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Heal 2017;5:e898–906. https://doi.org/10.1016/S2214-109X(17)30289-9. DOI: https://doi.org/10.1016/S2214-109X(17)30289-9
Dipiro JT, Tee GC, Haines ST, Nolin TD, Ellingrod V., Posey LM. Dipiro’SPharmacotherapya Pathophysiologic Approach 12Th Edition. 2023.
DIH 17th. Drug Information Handbook 17th Edition(3) 2009.
Yusuf D et al. Entcase 2016.
Latifah E, Yuniarti E, Susilo R, Karuniawati H, Azizah N, Perwitasari DA, et al. Implementation of Monitoring Side Effects of Drugs in Drug-Resistant Tuberculosis Patients in Referral Hospitals: a Qualitative Study. Med Sains J Ilm Kefarmasian 2024;9:973–86. https://doi.org/10.37874/MS.V9I4.1294. DOI: https://doi.org/10.37874/ms.v9i4.1294